What is the catalog number for BMPR2 Antibody (N-term) [APR04511G]?

The catalog number for BMPR2 Antibody (N-term) [APR04511G] is APR04511G.

What sizes are available for BMPR2 Antibody (N-term) [APR04511G]?

BMPR2 Antibody (N-term) [APR04511G] is available in the following size(s): 50 µL, 100 µL, 200 µL, 400 µL.

How many pack sizes does BMPR2 Antibody (N-term) [APR04511G] come in?

BMPR2 Antibody (N-term) [APR04511G] is available in 4 different pack sizes.

Is BMPR2 Antibody (N-term) [APR04511G] in stock?

BMPR2 Antibody (N-term) [APR04511G] is currently made to order / not held in immediate stock. Contact us for lead time.

BMPR2 Antibody (N-term) [APR04511G]

Product Specifications

Background

Tissue Location: Highly expressed in heart and liver.

Overview

We constantly strive to ensure we provide our customers with the best antibodies. As a result of this work we offer this antibody in purified format. We are in the process of updating our datasheets. If you have any questions regarding this update, please feel free to contact our technical support team. This product is a high quality BMPR2 Antibody (N-term) [APR04511G].

Synonyms

Bone morphogenetic protein receptor type-2, BMP type-2 receptor, BMPR-2, Bone morphogenetic protein receptor type II, BMP type II receptor, BMPR-II, BMPR2, PPH1

Gene Name

BMPR2

Gene ID

659

UniProt

Q13873

Chromosomal Location

Cell membrane; Single-pass type I membrane protein

Applications

WB, FC

Dilution

WB--1:1000 FC--1:10~50

Form

Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.

Function

On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Binds to BMP7, BMP2 and, less efficiently, BMP4. Binding is weak but enhanced by the presence of type I receptors for BMPs. Mediates induction of adipogenesis by GDF6.